- ►annals.org [PDF] SK Herrine - Annals of internal medicine, 2002 - Am Coll Physicians Chronic hepatitis C virus (HCV) infection is common and often asymptomatic.
Antibodies against HCV are a highly sensitive marker of infection. Molecular
testing for HCV is used to confirm a positive result on antibody testing ... Cited by 67 - Related articles - BL Direct - All 5 versions
THN Symptoms, WTAUT Screen - Ann Intern Med, 2002 - infeksiyon.org Chronic hepatitis C virus (HCV) infection is common and often asymptomatic.
Antibodies against HCV are a highly sensitive marker of infection. Molecular
testing for HCV is used to confirm a positive result on antibody testing ... Related articles - View as HTML - All 2 versions
[CITATION] Usefulness of erythropoietin and G-CSF during treatment for chronic hepatitis C with pegylated …
SD Scott - Pharmacotherapy, 2002 - PPI Anemia, defined as an inadequate level of either hemoglobin or red blood cells,
is common in patients with chronic kidney disease (CKD) or cancer, occurring in
80–90% of patients undergoing hemodialysis and over 50% of patients ... Cited by 12 - Related articles - BL Direct - All 2 versions
[CITATION] Erythropoietin maintains ribavirin dose and sustained virologic response during HCV …
A Pariente - Gastroentérologie Clinique et Biologique, 2003 - masson.fr 262 naïve patients were included. Patients were significantly older, had more
severe liver fibrosis, with cirrhosis in 17 percent, but were comparable for
sex, contamination mode and viral genotype with those of the Poynard et al. ... Cited by 13 - Related articles - Cached - BL Direct - All 3 versions
C Fang, P Srivastava, C Lin - Journal of Applied Toxicology, 2003 - interscience.wiley.com The ribavirin/interferon- combination is currently the standard therapy for
patients with chronic hepatitis C. However, ribavirin causes hemolytic anemia as
a significant side-effect. Levovirin, an l-enantiomer of ribavirin, ... Cited by 13 - Related articles - BL Direct - All 4 versions
